Fengli Xu, Jixiang Xu, Xia Xiong, & Yongqiong Deng. (2019). Salidroside inhibits MAPK, NF-κB, and STAT3 pathways in psoriasis-associated oxidative stress via SIRT1 activation. Taylor & Francis Group.
Chicago Style (17th ed.) CitationFengli Xu, Jixiang Xu, Xia Xiong, and Yongqiong Deng. Salidroside Inhibits MAPK, NF-κB, and STAT3 Pathways in Psoriasis-associated Oxidative Stress via SIRT1 Activation. Taylor & Francis Group, 2019.
MLA (9th ed.) CitationFengli Xu, et al. Salidroside Inhibits MAPK, NF-κB, and STAT3 Pathways in Psoriasis-associated Oxidative Stress via SIRT1 Activation. Taylor & Francis Group, 2019.
Warning: These citations may not always be 100% accurate.